Tender For purchase of pharmaceutical preparations - inj. oxytetracycline hydrochloride i.p. 50 mg/ per ml i/v.i/m & s/c (vety.), inj. oxytetracycline dihydrate i.p 200 mg per ml in vehicle system-2 pyrrolidone, each gram contains tetracycline hydrochloride i.p.50 mg, inj. calcium gluconate 10%, enrofloxacin 10% oral liquid, enrofloxacin 50 mg tablet, each vial contains ceftizoxime sodium 3000 mg, metronidazole 1000 mgurea 5000 mgnitrofurazone 60 mg, each vial contains:ceftiofur sodium sterile powder equivalent to ceftiofur activity 1 gm, each vial contains:ceftiofur sodium sterile powder equivalent to ceftiofur activity 500 mg, each uncoated bolus contains:cephalexin i.p. equivalent to anhydrous cephalexin 750 mg urea i.p. 2.5 g for intra uterine use., each ml contains:-levofloxacin 20 mg, ornidazole 40 mgalpha tocopherol 5 mg (for intra uterine use), oxytetracycline hydrochloride i.p 50 mg/ml (liquid) for topical & i/u use, single dose 6ml contains procaine penicillin g1 lac unit streptomycin sulphate i.p 100 mg sulphamerazine bp 500 mg. hydrocortizone acetate i.p 20 mg (intra mammary use), intramammary infusion, each 10 ml contains :-cefoperazone 250 mg, each bolus contains: trimethoprim ip 400 mg. ip sulphamethoxazole ip 2 gms , each ml contains:-ceftiofur hydrochloride 12.5 mg (for intramammary use), tylosin tartrate 50 % w/w excipitents q.s., each ml of suspension contains:29.64 mg cefquinome sulphate (equivalent to 25 mg cefquinome), each syringe contains 75 mg :-cefquinome sulphate as active ingredient (for intramammary use), each single dose syringe of 19 g contains 500 mg of cephapirin, each 3 g syringe contains 250 mg cefalonium dihydrate, each ml contains:marbofloxacin ip 100 mgwater for injection ip q.s., each bolus contains ofloxacin 1000 mg and ornidazole 2500 mg, each 3 ml contains sulphadimidine sodium ip 1000mg, each ml contains: sulphadiazine ip 200 mg and trimethoprim ip 40 mg, each tab contain:marbofloxacin 50 mg, each tablet contains:cephalexin ip 600 mg, each ml contains:inj. phenyl butazone i.p 200 mg, sodium salicylate ip 20 mg , each ml contains:-tolfenamic acid 40 mg, , each ml contains:-tolfenamic acid 40 mg, , each bolus contains:-meloxicam 100 mg, each ml contains dexamethasone sodium phosphate i.p 4.4 mg equivalent to dexamethasone 3.344 mg, each ml contains dexamethasone sodium phosphate i.p 4.4 mg equivalent to dexamethasone 3.344 mg, inj. ondansetron 4 mg / 2.0 ml, inj. betamethazone sodium phosphate b.p 4 mg/ml, inj. triamcinolone acetonide 6 mg/ml, inj. isoflupredone acetate 2 mg/ml, inj. pheniramine maleate i.p 22.75 mg/ml, each ml contains:- doramectin - 10 mg, griseofulvin 125 mg. tablets, tetramisole powder 30% w/w, fenbendazole feed pellets:-each 100 gm feed pellet contains fenbendazole 600 mg, inj. lithium antimony thiomalate solution 6% w/v, each ml contains; triclabendazole 50 mg, ivermectin 1 mg, each ml contains; triclabendazole 50 mg, ivermectin 1 mg, each ml contains: deltamethrin ip 12.5 mg, each ml contains: deltamethrin ip 12.5 mg, each ml contains: deltamethrin ip 12.5 mg, xylazine injection contains xylazine 23.32 mg chlorocresol ip as preservative, xylazine injection contains xylazine 23.32 mg chlorocresol ip as preservative, inj. triflupromazine hydrochloride usp 20 mg per ml, inj. lignocaine hydrochloride i.p 2%, each ml contains:ethamsylate 125 mg, each ml contains; xylazine hydrochloride 23.32 mg, chlorocresol 0.1% w/v, eto theophyline (etophyllin i.p. 169.4 mg + theophylline hydrate i.p. 50.6 mg), inj. aminophylline (each 10 ml. containing aminophylline 2.5%), inj. adrenaline b.p vet 1 in 1000 adrenaline acid tartrate b. vet 1.8 mg, inj. atropine sulphate b.p vet 1.0 mg/ml, inj. ketamine 50 mg/ml, each ml contains:diazepam 5 mg, inj. buserelin 0.004 mg/ml, inj. valethamate bromide 10 mg / ml, intravaginal hormonal implanting device made up to silicon elastomer moulded over a nylon spine. set of 10 devices in one pack releasing progesterone (with one applicator), each ml c